Lamivir Tablets (Generic Lamivudine Tablets)

© Clearsky Pharmacy ( www.clearskypharmacy.biz ) Lamivir Tablets (Generic Lamivudine Tablets) Lamivir Tablets (Generic Lamivudine Tablets) are used in combination with other antiretroviral agents for the treatment of HIV-1 infection.

© Clearsky Pharmacy ( www.clearskypharmacy.biz ) Lamivir Tablets (Generic Lamivudine Tablets) Active Ingredient The active ingredient present in Lamivir HBV and Lamivir tablets is Lamivudine. Each Lamivir tablet contains 150 mg of Lamivudine.

© Clearsky Pharmacy ( www.clearskypharmacy.biz ) Lamivir Tablets (Generic Lamivudine Tablets) Lamivir Tablets are manufactured by Cipla Limited, India in the strength of 150 mg. ( Website: https://www.cipla.com/ ) URL: https://www.clearskypharmacy.biz/lamivudine-tablets.html

© Clearsky Pharmacy ( www.clearskypharmacy.biz ) Lamivir Tablets (Generic Lamivudine Tablets) Lamivudine Tablets – Brand Names Lamivudine tablets are available under various drug trade names that include Epivir-HBV, Epivir, Lamivir HBV, Lamivir, Hepitec, Hepavud, Lamda, Lami, Lamidac, Lamuvid, Retrolam, Viramid and Virolam.

Lamivir Tablets)

Uses of Lamivir Tablets

Tablets (Generic Lamivudine

Lamivudine will not cure or prevent HIV infection or AIDS. It helps keep HIV from reproducing and appears to slow down the destruction of the immune system. This may help delay the development of serious health problems usually related to AIDS or HIV disease from occurring. Lamivudine will not keep you from spreading HIV to other people. People who receive this medicine may continue to have other problems usually related to AIDS or HIV disease.

Lamivir Tablets (Generic Lamivudine Tablets) are used in combination with other medicines for the treatment of the infection caused by the human immunodeficiency virus (HIV). HIV is the virus that causes acquired immune deficiency syndrome (AIDS).

URL: https://www.clearskypharmacy.biz/lamivudine-tablets.html

The dosage of Lamivir tablets (Generic Lamivudine Tablets) is given Thebelow:recommended dosage of Lamivir (Generic Lamivudine Tablets) in HIV-1 infected adults is 300 mg daily, administered as either 150 mg taken orally twice daily, or 300 mg taken orally once daily with or without food. If Lamivudine is administered to a patient infected with HIV-1 and HBV, the dosage indicated for HIV-1 therapy should be used as part of an appropriate combination regimen. Patients with Renal Impairment: Dosing of Lamivir is adjusted in accordance with renal function. Reduction of the dosage of is recommended for patients with impaired renal function. URL: https://www.clearskypharmacy.biz/lamivudine-tablets.html

Lamivir Tablets Dosage

© Clearsky Pharmacy ( www.clearskypharmacy.biz ) Lamivir Tablets (Generic Lamivudine Tablets) Contraindications Lamivir Tablets are contraindicated in patients with a hypersensitivity to Lamivudine or any other component of this medication. URL: https://www.clearskypharmacy.biz/lamivudine-tablets.html

© Clearsky Pharmacy ( www.clearskypharmacy.biz ) Lamivir Tablets (Generic Lamivudine Tablets) Storage Instructions Lamivir Tablets (Generic Lamivudine Tablets) have to be stored at controlled room temperature i.e. from 20°C to 25°C (68°F to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). Keep this as well as all other medicines away from children and pets. URL: https://www.clearskypharmacy.biz/lamivudine-tablets.html

In pediatric patients with a history of prior antiretroviral nucleoside exposure, a history of pancreatitis, or other significant risk factors for the development of pancreatitis, Lamivudine should be used with caution.

URL: https://www.clearskypharmacy.biz/lamivudine-tablets.html

Treatment with Lamivir should be stopped immediately if clinical signs, symptoms, or laboratory abnormalities suggestive of pancreatitis occur. Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogues alone or in combination, including Lamivudine and other antiretrovirals. Severe acute exacerbations of hepatitis: Reported in patients who are coinfected with hepatitis B virus and HIV-1 and discontinued Lamivudine (Lamivir tablets). Monitor hepatic function closely in these patients and, if appropriate, begin anti-hepatitis B treatment.

Lamivir Tablets (Generic Lamivudine Tablets) Warnings

Patients with HIV-1 infection should receive only dosage forms of Lamivudine Tablets appropriate for treatment of HIV-1. Co-infected HIV-1/HBV Patients: Emergence of Lamivudine-resistant HBV variants associated with lamivudine-containing antiretroviral regimens has been reported. Emtricitabine should not be administered concomitantly with Lamivudine containing products. Hepatic decompensation (some fatal) has occurred in HIV-1/HCV co-infected patients receiving Interferon and Ribavirin-based regimens. Monitor for treatment-associated toxicities. Discontinue Lamivudine as medically appropriate and consider dose reduction or discontinuation of Interferon Alfa, Ribavirin, or both.

Immune reconstitution syndrome and redistribution/accumulation of body fat have been reported in patients treated with combination antiretroviral therapy. URL: https://www.clearskypharmacy.biz/lamivudine-tablets.html

URL: https://www.clearskypharmacy.biz/lamivudine-tablets.html

The most common reported Lamivudine Tablets (Lamivir Tablets) side effects with an incidence rate greater than or equal to 15% in adults were headache, nausea, malaise and fatigue, nasal signs and symptoms, diarrhea, and cough.Themost common reported side effects with an incidence rate greater than or equal to 15% in pediatric subjects were fever and cough.

Lamivir Tablets Side Effects

There is no known specific treatment for overdose with Lamivudine Tablets (Lamivir Tablets). In case overdose occurs, the patient should be monitored and standard supportive treatment applied as necessary. Since a negligible amount of Lamivudine was removed via (4-hour) hemodialysis, continuous ambulatory peritoneal dialysis, and automated peritoneal dialysis, it is not known if continuous hemodialysis would provide clinical benefit in a Lamivudine overdose event.

URL: https://www.clearskypharmacy.biz/lamivudine-tablets.html

Overdose

Lamivir Tablets During Pregnancy

While early embryolethality was observed in rabbit studies with an exposure levels similar to human levels, this effect was not observed in high-dose studies in rats. Placental transfer has been observed in humans. There are no controlled data in human pregnancy.

Lamivudine Tablets (Lamivir Tablets) has been classified by the US FDA as Pregnancy Category C. This medicine should be used during pregnancy only if clinically needed and the benefit outweighs the risk to the fetus. Animal studies have failed to show evidence of teratogenicity.

URL: https://www.clearskypharmacy.biz/lamivudine-tablets.html

© Clearsky Pharmacy ( www.clearskypharmacy.biz ) Lamivir Tablets (Generic Lamivudine Tablets) For more details on Lamivir Tablets click here Lamivir Tablets (Generic Lamivudine Tablets) by Cipla Limited, India. URL: https://www.clearskypharmacy.biz/lamivudine-tablets.html

Turn static files into dynamic content formats.

Create a flipbook